Inorganic bismuth(III) compounds in the therapy

Area of Science:

• Pharmacology
• Inorganic Chemistry

Background:

• Bismuth compounds have a long history of medicinal use.
• Pharmacopoeial preparations require standardized methods for quality control.

Purpose of the Study:

• To survey pharmacopoeial preparations of inorganic bismuth(III) compounds.
• To review the uses, preparation methods, and assays for bismuth subnitrate and bismuth subcarbonate.

Main Methods:

• Literature review of pharmacopoeial standards and scientific publications.
• Analysis of preparation methods for bismuth subnitrate and subcarbonate.
• Examination of qualitative and quantitative assay techniques.

Main Results:

• Bismuth subnitrate and bismuth subcarbonate are key inorganic Bi(III) compounds in pharmacopoeias.
• Established methods exist for their preparation and quality assessment.
• Various qualitative and quantitative assays are employed to ensure purity and potency.

Conclusions:

• Pharmacopoeial standards ensure the quality and efficacy of bismuth subnitrate and subcarbonate.
• Understanding preparation and assay methods is crucial for pharmaceutical applications.
• These inorganic bismuth compounds remain relevant in medicinal chemistry.